Ben Franklin Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners of Southeastern Pennsylvania, established in 1982, is a non-profit organization that fosters technological innovation and growth in the region. It primarily invests in early-stage technology companies, having supported over 1,750 such ventures since its inception. The organization also facilitates university-industry partnerships to accelerate scientific discoveries to market, and initiates regional programs to bolster the entrepreneurial ecosystem. Its mission is to create jobs and transform lives by leading the region's technology community to new heights.
Investment Director, Information Technology Investment Group
Anthony George
Venture Capital Associate, Tech Investment Group
Adare McMillan
CFO
Omar Mencin
Managing Director, Information Technology Investment Group
Scott Nissenbaum
President, CEO and Board Member
Aston Pierce
Director - GO PA Fund and GO PHL Fund
Kathie Jordan Ph.D
Managing Director, Healthcare Investment Group
Past deals in Nanotechnology
Avisi Technologies
Seed Round in 2022
Avisi Technologies Inc. is a Philadelphia-based company founded in 2017 that specializes in developing innovative solutions for glaucoma treatment. Its primary product, VisiPlate, is a next-generation, nanotechnology-enabled aqueous shunt designed to prevent blindness caused by glaucoma. Through its advanced technology, Avisi Technologies aims to enhance the effectiveness of glaucoma management and improve patient outcomes.
Avisi Technologies
Seed Round in 2021
Avisi Technologies Inc. is a Philadelphia-based company founded in 2017 that specializes in developing innovative solutions for glaucoma treatment. Its primary product, VisiPlate, is a next-generation, nanotechnology-enabled aqueous shunt designed to prevent blindness caused by glaucoma. Through its advanced technology, Avisi Technologies aims to enhance the effectiveness of glaucoma management and improve patient outcomes.
Avisi Technologies
Seed Round in 2019
Avisi Technologies Inc. is a Philadelphia-based company founded in 2017 that specializes in developing innovative solutions for glaucoma treatment. Its primary product, VisiPlate, is a next-generation, nanotechnology-enabled aqueous shunt designed to prevent blindness caused by glaucoma. Through its advanced technology, Avisi Technologies aims to enhance the effectiveness of glaucoma management and improve patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.